GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
F

Fuso Pharmaceutical Industries 4538.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

2,130

+1.87%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in JPY, from our data supplier.

FY2026

Revenue

¥62.31bn

FY2017FY2026

Net income

¥2.01bn

FY2017FY2026

Free cash flow

−¥7.49bn

FY2017FY2026

Shareholders' equity

¥35.06bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue¥62.31bn¥60.56bn¥55.41bn¥51.02bn¥49.63bn¥49.25bn¥46.90bn¥46.07bn¥45.90bn¥46.78bn
Gross profit¥15.99bn¥16.19bn¥13.52bn¥13.36bn¥12.91bn¥13.62bn¥12.29bn¥12.93bn¥12.78bn¥12.70bn
Research and development—¥1.72bn¥1.47bn¥1.35bn¥1.44bn¥1.46bn¥1.41bn¥1.76bn¥2.00bn¥2.09bn
Operating income¥2.64bn¥4.13bn¥1.97bn¥2.21bn¥1.92bn¥2.35bn¥1.23bn¥1.26bn¥799.0m¥657.0m
Net income¥2.01bn−¥3.29bn¥1.38bn¥1.60bn¥1.48bn¥1.61bn¥707.0m¥894.0m¥970.0m¥861.0m
Diluted earnings per share235.57-385.12161.21189.67169.09183.1980.59101.88110.5398.08

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets¥90.32bn¥82.52bn¥76.46bn¥72.81bn¥69.66bn¥70.23bn¥69.40bn¥72.18bn¥70.65bn¥69.16bn
Cash and short-term investments¥4.85bn¥6.26bn¥5.12bn¥8.01bn¥7.35bn¥7.07bn¥7.27bn¥5.73bn¥5.46bn¥4.95bn
Total liabilities¥55.26bn¥49.48bn¥39.79bn¥37.15bn¥35.12bn¥36.54bn¥37.09bn¥39.33bn¥38.06bn¥36.61bn
Debt¥28.46bn¥21.29bn¥12.72bn¥11.41bn¥12.09bn¥13.20bn¥15.10bn¥17.00bn¥16.18bn¥16.62bn
Shareholders' equity¥35.06bn¥33.04bn¥36.66bn¥35.65bn¥34.53bn¥33.68bn¥32.30bn¥32.84bn¥32.58bn¥32.55bn
Shares outstanding9m9m9m8m9m9m9m9m9m9m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations−¥6.22bn−¥3.31bn¥627.0m¥2.85bn¥3.50bn¥3.23bn¥5.73bn¥2.15bn¥1.53bn¥2.03bn
Capital spending−¥1.27bn−¥2.12bn−¥3.25bn−¥1.57bn−¥1.49bn−¥1.21bn−¥2.50bn−¥2.30bn−¥961.0m−¥1.84bn
Free cash flow−¥7.49bn−¥5.43bn−¥2.62bn¥1.28bn¥2.01bn¥2.02bn¥3.22bn−¥150.0m¥566.0m¥192.0m
Dividends paid−¥734.0m−¥638.0m−¥645.0m−¥525.0m−¥525.0m−¥525.0m−¥613.0m−¥700.0m−¥706.0m−¥717.0m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue¥16.05bn¥14.04bn¥17.04bn¥15.73bn¥15.50bn¥13.90bn¥16.92bn¥15.12bn
Gross profit¥4.20bn¥3.47bn¥4.42bn¥4.03bn¥4.08bn¥3.88bn¥4.27bn¥4.21bn
Operating income¥973.0m¥271.0m¥1.12bn¥650.0m¥597.0m¥497.0m¥1.20bn¥1.28bn
Net income¥642.0m¥327.0m¥853.0m¥369.0m¥462.0m−¥5.69bn¥867.0m¥903.0m
Diluted earnings per share75.2138.3199.9143.2254.11-666.46101.50105.72
Total assets¥87.47bn¥90.32bn¥89.45bn¥85.43bn¥86.99bn¥82.52bn¥80.71bn¥76.00bn
Cash and short-term investments¥4.57bn¥4.85bn¥6.88bn¥4.64bn¥3.16bn¥6.26bn¥7.17bn¥4.62bn
Debt¥24.49bn¥28.46bn¥27.62bn¥26.28bn¥25.82bn¥21.29bn¥18.51bn¥13.80bn
Shareholders' equity¥35.75bn¥35.06bn¥34.66bn¥34.01bn¥33.18bn¥33.04bn¥38.71bn¥37.90bn

Financial ratios

Data as of 25 Sept 2026

FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin25.7%26.7%24.4%26.2%26.0%27.7%—
Operating margin4.2%6.8%3.5%4.3%3.9%4.8%—
Net margin3.2%-5.4%2.5%3.1%3.0%3.3%—
Return on equity5.7%-10.0%3.8%4.5%4.3%4.8%—
Return on assets2.2%-4.0%1.8%2.2%2.1%2.3%—
Free cash flow yield-25.8%-6.2%20.2%23.3%25.3%22.5%—
Revenue growth2.9%9.3%8.6%2.8%0.8%5.0%—
Earnings growth-161.2%-338.8%-14.2%8.2%-7.7%127.3%—
Current ratio1.11x1.10x1.52x1.52x1.51x1.48x—
Debt to equity0.81x0.64x0.35x0.32x0.35x0.39x—
Equity ratio38.8%40.0%47.9%49.0%49.6%48.0%—
Interest coverage8.05x25.66x11.49x13.38x10.93x11.99x—
R&D as a share of sales—2.8%2.7%2.7%2.9%3.0%3.0%
Buybacks as a share of market value0.0%0.0%-0.9%3.5%0.0%0.0%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue6.9%4.8%3.1%
Operating income6.2%2.3%24.5%
Net income7.8%4.6%70.0%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin26.2%25.8%26.1%26.5%
Operating margin5.5%4.8%4.6%3.5%
Net margin-1.0%0.7%1.5%1.5%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings8.9-6.015.810.011.814.234.820.223.429.5
Price to sales0.30.30.40.30.30.50.50.40.50.5

Dividends and splits

Per share, in the currency the company pays

Paid for 36 years. Last went ex-dividend on 30 Mar 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year132.0075.0075.0060.0060.0060.0070.0080.00
  • 10-to-1 reverse split · 28 Sept 2016
  • 1.1-for-1 split · 26 Mar 1992
  • 11-for-10 split · 26 Mar 1991
  • 11-for-10 split · 27 Mar 1990
  • 11-for-10 split · 28 Mar 1989

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.